Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eva Rihackova"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Treatment of malignant lymphoma has for years been represented by many cardiotoxic agents especially anthracyclines, cyclophosphamide, and thoracic irradiation. Although they are in clinical practice for decades, the precise mechanism of cardiotoxici
Externí odkaz:
https://doaj.org/article/91e4c0080c264fac809b97e86a95d172
Autor:
Michal Rihacek, Iveta Selingerova, Ivo Kocak, Ilona Kocakova, Eva Rihackova, Dalibor Valik, Jaroslav Sterba
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4138-4147 (2022)
Sunitinib is a broad-spectrum multitargeted tyrosine kinase inhibitor mainly used as second-line therapy for non-resectable gastrointestinal stromal or first-line treatment option of metastatic renal cell carcinoma (mRCC), and as an “off-label” o
Externí odkaz:
https://doaj.org/article/1757570502894c7cbe87bb75a91e573a
Autor:
Eva Rihackova, Petra Vysocanova, Michal Rihacek, Dominika Kucerova, Tereza Blahovcova, Petr Kala
Publikováno v:
Medicina, Vol 59, Iss 1, p 88 (2022)
We present a case of a pregnant woman with systemic lupus erythematosus (SLE) who was diagnosed with asymptomatic complete heart block (CHB) during pregnancy. To evaluate possible risks and benefits of pacemaker (PM) implantation, a multidisciplinary
Externí odkaz:
https://doaj.org/article/496157594e23474d95c1bb0056f3abef
Autor:
Michal, Rihacek, Andrea, Wagnerova, Jana, Halamkova, Lucie, Pehalova, Eva, Rihackova, Lubos, Boucek, Kateřina, Kapounková, Iva, Hrnčiříková, Igor, Kiss
Publikováno v:
In Heliyon 30 October 2024 10(20)